期刊文献+

临床药师对1例淋巴瘤患儿的药学监护 被引量:1

Pharmaceutical Care for a Child with Lymphoma by Clinical Pharmacist
原文传递
导出
摘要 目的:探讨临床药师对淋巴瘤患儿的药学监护点,促进临床合理用药。方法:临床药师通过参与1例10岁T细胞性淋巴母细胞淋巴瘤患儿的化疗过程,首先针对患儿多程化疗后病情复发,且因蒽环类药物累计剂量造成心功能损伤的情况,协助医师制订化疗方案为改良的BFM-90方案;然后对化疗中出现的左旋门冬酰胺酶致凝血功能障碍、泼尼松致胃肠道反应、5-HT3受体拮抗药致中枢神经系统不良反应及对患儿的用药教育等方面提供药学监护。结果:患儿因化疗引起的凝血功能障碍、胃肠道反应及中枢神经系统反应等不良反应明显减轻,化疗顺利实施。结论:临床药师利用自身的专业知识,参与特殊人群中儿童的肿瘤化疗经过,监测抗肿瘤药物不良反应并制订合理的监护方案,体现了临床药师在肿瘤儿童患者药物治疗中的积极作用。 OBJECTIVE: To discuss the pharmaceutical care for a child with lymphoma in order to improve the rational use of drugs in the clinic. METHODS: By involving chemotherapy course of a 10-year-old child diagnosed as T lymphoblastic lym phoma, clinical pharmacist assisted doctors to formulate modified BFM-90 chemotherapy scheme for the patient whose condi tion relapsed after several chemotherapy courses and the heart function was impaired by accumulated doses of anthracyclines drug. Then clinical pharmacist provided pharmaceutical care on ADR, such as L-asparaginase induced coagulation disorder, gas trointestinal reaction of prednisone and central nervous system ADR caused by 5-HT3 antagonist, and provided medication educa tion for the child. RESULTS: The impaired coagulation function was improved, while the gastrointestinal adverse reaction and the central nervous system adverse reaction caused by chemotherapy were significantly relieved. The chemotherapy was success- fully carried out. CONCLUSIONS: Clinical pharmacists use their professional knowledge to participate in the chemotherapy courses of child to monitor ADR and provide rational pharmaceutical care, which reflect their own value in the chemotherapeu-tic dru treatment.
作者 贾毅敏 张援
出处 《中国药房》 CAS CSCD 2014年第6期574-576,共3页 China Pharmacy
关键词 淋巴瘤 药品不良反应 临床药师 药学监护 Lymphoma ADR Clinical pharmacist Pharmaceutical care
  • 相关文献

参考文献8

二级参考文献83

  • 1路瑾,黄晓军,单福香,江滨,孔圆,陆道培.左旋门冬酰胺酶不同用法副作用的观察[J].中国综合临床,2004,20(7):605-606. 被引量:4
  • 2李文瑜,费洪文,陆泽生.无创监测表阿霉素心脏毒性-组织多普勒超声心动图[J].中国病理生理杂志,2006,22(10):1983-1986. 被引量:20
  • 3PUI C H,BURGHEN G A,BOWMAN W P,et al.Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone[J].J Pediatr,1981,99(1):46-50.
  • 4PRIEST J R,RAMSAY N K,STEINHERZ P G,et al.Asyndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute 2.lymphoblastic leukemia[J].J Pediatr,1982,100(6):984-989.
  • 5SAHU S,SAIKA S,PAI S K,et al.L-asparaginase(Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia[J].Pediatr Hematol Oncol,1998,15(6):533-538.
  • 6TANIMOTO M,MIYAWAKI S,INO T,et al.Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia:the ALL-87 Study of the Japan Adult Leukemia Study Group (JALSG)[J].Int J Hematol,1998,68(4):421-429.
  • 7ROWE J M,BUCK G,BURNETT A K,et al.XII/ECOG E2993 of more than 1500 5.patients from the international ALL trial:MRC UKALL induction therapy for adults 5.with acute lymphoblastic leukemia:results[J].Blood,2005,106(12):3760-3767.
  • 8SCHRAPPE M,REITER A,LUDWIG W D,et al.Improved outcome in childhood acute 5.lymphoblastic leukemia despite reduced use of anthracyclines and cranial 6.radiotherapy:results of trial ALL-BFM 90[J].Blood,2000,95(11):3310-3322.
  • 9DUVAL M,SUCIU S,FERSTER A,et al.Comparison of Escherichia coli-5.asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid 5.malignancies:results of a randomized European Organisation for Research and 5.Treatment of Cancer-Children′s Leukemia Group phase 3 trial[J].Blood,2002,99(8):2734-2739.
  • 10PANOSYAN E H,SEIBEL N L,MARTIN ARAGON S,et al.Asparaginase antibody and 10.asparaginase activity in children with higher-risk acute lymphoblastic leukemia:10.Children′s Cancer Group Study CCG-1961[J].J Pediatr Hematol Oncol,2004,26(4):10.217-226.

共引文献134

同被引文献16

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部